Williams JW - Search Results

1

Transcriptional regulation of Fas gene expression by GA-binding protein and AP-1 in T cell antigen receptor.CD3 complex-stimulated T cells.

Li XR, Chong AS, Wu J, Roebuck KA, Kumar A, Parrillo JE, Rapp UR, Kimberly RP, Williams JW, Xu X. Li XR, et al. Among authors: williams jw. J Biol Chem. 1999 Dec 3;274(49):35203-10. doi: 10.1074/jbc.274.49.35203. J Biol Chem. 1999. PMID: 10575005 Free article.

2

Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide.

Xu X, Williams JW, Bremer EG, Finnegan A, Chong AS. Xu X, et al. Among authors: williams jw. J Biol Chem. 1995 May 26;270(21):12398-403. doi: 10.1074/jbc.270.21.12398. J Biol Chem. 1995. PMID: 7759480 Free article.

3

Regulation of B cell function by the immunosuppressive agent leflunomide.

Siemasko KF, Chong AS, Williams JW, Bremer EG, Finnegan A. Siemasko KF, et al. Among authors: williams jw. Transplantation. 1996 Feb 27;61(4):635-42. doi: 10.1097/00007890-199602270-00020. Transplantation. 1996. PMID: 8610393

4

Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production.

Siemasko K, Chong AS, Jäck HM, Gong H, Williams JW, Finnegan A. Siemasko K, et al. Among authors: williams jw. J Immunol. 1998 Feb 15;160(4):1581-8. J Immunol. 1998. PMID: 9469413

5

Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro.

Chong AS, Rezai K, Gebel HM, Finnegan A, Foster P, Xu X, Williams JW. Chong AS, et al. Among authors: williams jw. Transplantation. 1996 Jan 15;61(1):140-5. doi: 10.1097/00007890-199601150-00026. Transplantation. 1996. PMID: 8560553

6

Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation.

Xu X, Williams JW, Gong H, Finnegan A, Chong AS. Xu X, et al. Among authors: williams jw. Biochem Pharmacol. 1996 Aug 23;52(4):527-34. doi: 10.1016/0006-2952(96)00303-6. Biochem Pharmacol. 1996. PMID: 8759024

7

The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms.

Elder RT, Xu X, Williams JW, Gong H, Finnegan A, Chong AS. Elder RT, et al. Among authors: williams jw. J Immunol. 1997 Jul 1;159(1):22-7. J Immunol. 1997. PMID: 9200434

8

Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: mechanisms of action.

Xu X, Gong H, Blinder L, Shen J, Williams JW, Chong AS. Xu X, et al. Among authors: williams jw. J Pharmacol Exp Ther. 1997 Nov;283(2):869-75. J Pharmacol Exp Ther. 1997. PMID: 9353408

9

In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action.

Xu X, Shen J, Mall JW, Myers JA, Huang W, Blinder L, Saclarides TJ, Williams JW, Chong AS. Xu X, et al. Among authors: williams jw. Biochem Pharmacol. 1999 Nov 1;58(9):1405-13. doi: 10.1016/s0006-2952(99)00228-2. Biochem Pharmacol. 1999. PMID: 10513984

10

Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation.

Chong AS, Finnegan A, Jiang X, Gebel H, Sankary HN, Foster P, Williams JW. Chong AS, et al. Among authors: williams jw. Transplantation. 1993 Jun;55(6):1361-6. doi: 10.1097/00007890-199306000-00028. Transplantation. 1993. PMID: 8390735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

698 results

Search Page

Filters